socaltech | Shared With: Everyone - Aug 08 2006 | cabrellis, cancer, lung, domain, associates, venture, capital, vc, investment, funding, anthracycline, socaltechSan Diego-based Cabrellis Pharmaceuticals, which is developing treatments for cancer, said Monday that it has raised $27.5M in a Series A funding round. Funding came from Domain Associates, Forward Ventures, Lilly Ventures, Novo A/S, ProQuest Investments,
Related Content from Around Faves
venture
-
Met one of the team members this weekend. They operate out of Boston and Seattle and invest in life science and information technology businesses.
1 FaverViewed: 4 TimesQuoted: Polaris Venture Partners invests in seed and early stage companies and in growth equity companies with substantial operating income. We have over $2 billion under management and current investments in more than 60 companies.
- diamondjewler - 18 days ago1 Faver
- WebUp1 - 20 days ago1 FaverViewed: 2 Times
investment
-
This is not too surprising given Japan's dependency on U.S. consumers.
Let's see how this affects the U.S. markets tomorrow.
1 FaverViewed: 3 TimesQuoted: Japan’s economy has been hurt by weak export growth and steep cuts in corporate spending amid the worsening global slowdown.
- ClaraSet - 17 hours ago7 Favers
- ClaraSet - 21 hours ago3 Favers
